Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214519 · ClinicalTrials.gov registry record · NA
Permanent Supportive Housing Overdose Prevention+ Study
A NA study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- NA
- Development phase
- 2,940
- Enrollment target
NCT07214519 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 2,940 participants.
The verdict
NCT07214519, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 2,940 participants
- Enrollment target
Study Summary
This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based practices to prevent tenant overdose and improve tenant health.
Interventions
- BEHAVIORAL TA Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,940 participants |
| Start Date | 2027-07-01 |
| Est. Completion | 2031-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07214519
The ClinicalTrials.gov registry entry for NCT07214519 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 2,940 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TA Intervention is the first listed.
NCT07214519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07214519 about?
NCT07214519 is a clinical study titled "Permanent Supportive Housing Overdose Prevention+ Study". This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based practices to prevent tenant overdose and improve tenant health.
What is the current status of trial NCT07214519?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 2,940 participants. The study started on 2027-07-01. Estimated completion is 2031-03-31.
What interventions are being tested in trial NCT07214519?
The interventions under investigation include: TA Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07214519?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.